ATOM INDONESIA JOURNAL
Author’s Responses toward Associate Editor's Report
Article No. : #437
Title of Paper : Radiolabeled Antibody Fragment for Preparation of(177Lu)n-(DOTA)m- PAMAM G3.0-F(ab’)2-trastuzumab as Radiopharmaceutical for Cancer Therapy
Name of All Authors :
Criteria Evaluation Associate editor's evaluation
Author’s Responses
Yes No Comments
1. Originality of the article
Free of
Plagiarism/Similarity (max 20%)
V
New article/ not yet Published (presented/ in proceeding max 30%)
V
2. Related to nuclear/atomic
science and technology V 3. Reference
The number of references
at least 10 V
The use of recent
references 80% (maximum 5 years ago)
v The number of your recent references (2011-now) 13/15 less than 80%. The use international journal is reccomended.
93% of the references in this article between 2011-2015
Type of the references (primarily, secondary etc.) 85% from journal
v
References 1, 3, 12, 14, 15, 16, 17 not journal.
Please use internatioanl journals
86 % of the references are journal
Cross link reference (traceable)
Reference style standard:
Elsevier numeric without title
v Reference style for journal must follow the Atom Indonesia.
True example ( add page numbers) : R.D. Haryuni, A.
Bahtiar, S. Soenarjo, Y.
Harahap, A. Mutalib, M.
Ramli, S.
Hermanto, C.N.
Ardiyatno, V.Y. Susilo, and
D. Haffid, Atom Indonesia, 40(2014),13.
References has been followed the rules of Atom Indonesia Journal
Article follows the Atom Indonesia template and guidelines
v
Table (clear, without vertical line)
v Remove the vertical lines
There is no vertical lines on table
Figure (clear, min 300 dpi)
v Quality of Figure must be improved, so can be clearly seen in the pdf.
Figures 4, 5, 6 should be changed into closed figure.
Maximum quality of figure has been showed
Final recommendation:
1. Continue review process [ ] 2. Return to the Author [v]
3. Reject [ ]
Comments:
The author should revise the article as suggested above, before further substance review.
